Related Experiment Video
Updated: Apr 18, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.6K
New Perspectives of HIV/AIDS Therapy Study
Da-Yong Lu1, Ting-Ren Lu, Jin-Yu Che
1School of Life Sciences, Shanghai University, Shanghai200444, PR China. ludayong@shu.edu.cn.
Recent Patents on Anti-Infective Drug Discovery
|January 13, 2015
Summary
High-active anti-retroviral therapy (HAART) manages HIV/AIDS but cannot eradicate the virus, posing risks of drug resistance and new epidemics. Innovative strategies and global collaboration are crucial for future HIV/AIDS treatment advancements.
Area of Science:
- Infectious Diseases
- Virology
- Immunology
Background:
- HIV/AIDS was a leading cause of death in the US, but HAART significantly improved patient survival.
- Current HAART therapies manage HIV/AIDS as a chronic condition, not a cure, due to the inability to eradicate the virus.
- Emerging concerns include drug-resistant HIV strains and potential new epidemics.
Purpose of the Study:
- To outline the significant drawbacks and limitations of current HIV/AIDS therapies.
- To highlight potential future solutions and research directions for combating HIV/AIDS.
- To emphasize the need for innovative approaches and global cooperation in HIV/AIDS research and treatment.
Main Methods:
- Review of existing HIV/AIDS treatment strategies, focusing on HAART.
- Analysis of the limitations and challenges associated with current antiviral therapies.
- Exploration of potential future therapeutic avenues and research priorities.
Main Results:
- HAART has transformed HIV/AIDS from a fatal illness to a manageable chronic condition.
- Complete eradication of HIV remains unachieved, leaving patients vulnerable to viral persistence and resistance.
- The study identifies critical weaknesses in current treatment paradigms.
Conclusions:
- Overcoming HAART limitations requires novel strategies beyond current antiviral drug cocktails.
- Addressing the threat of drug resistance and viral mutations is paramount for global HIV/AIDS control.
- Enhanced global collaboration among researchers, developers, and funding bodies is essential for advancing HIV/AIDS therapies.
Related Concept Videos
01:10Retrovirus Life Cycles
50.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.8K
01:26Sexually Transmitted Infections
1.8K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.8K